Cognitive Health & Digital Biomarker Technologies | Altoida
Ιωάννης Ταρνανάς - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Ioannis Tarnanas - Worldwebforum
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Cognitive Health & Digital Biomarker Technologies | Altoida
Greek Researcher Receives Top European Innovation Award (video)
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas | Nature Portfolio Health Community
Ioannis Tarnanas's email & phone | Altoida's Founder email
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
A brain fitbit that can spot Alzheimer's with up to 94% accuracy
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas - Worldwebforum
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
